Line 3: Line 3:  
==Innate immunity==
 
==Innate immunity==
 
This becomes active during the early stages of infection. Defences include:
 
This becomes active during the early stages of infection. Defences include:
*Interferon (IFN) - typically stimulates the inhibition of viral replication. There are three known types:
+
*[[Cytokines|Interferon (IFN)]] - typically stimulates the inhibition of viral replication. There are three known types:
 
**Infection of a cell by a virus stimulates production of IFN-α and IFN-β, which activate genes in neighbouring cells. One of these genes, for example, codes for a protein kinase that blocks translation of proteins. Another activates an endonuclease that degrades viral RNA.  
 
**Infection of a cell by a virus stimulates production of IFN-α and IFN-β, which activate genes in neighbouring cells. One of these genes, for example, codes for a protein kinase that blocks translation of proteins. Another activates an endonuclease that degrades viral RNA.  
 
**IFN-γ increases the expression of MHC I and II, enhancing the function of the adaptive immune response. It also activates macrophages and NK cells.
 
**IFN-γ increases the expression of MHC I and II, enhancing the function of the adaptive immune response. It also activates macrophages and NK cells.
Line 13: Line 13:  
[[Image:B Cell viral response.jpg|thumb|right|200px|B Cell Immunity to Viruses - B. Catchpole, RVC 2008]]
 
[[Image:B Cell viral response.jpg|thumb|right|200px|B Cell Immunity to Viruses - B. Catchpole, RVC 2008]]
   −
*[[Immunoglobulin|Antibodies]] - these are particularly important in preventing the spread of the virus in the bloodstream
+
*[[Immunoglobulins|Antibodies]] - these are particularly important in preventing the spread of the virus in the bloodstream
 
**[[IgA]] production is increased at mucosal surfaces- helps prevent reinfection
 
**[[IgA]] production is increased at mucosal surfaces- helps prevent reinfection
 
**Although antibodies that target any viral protein can be produced, only those directed against proteins found in the virion envelope or infected cell membrane will be effective
 
**Although antibodies that target any viral protein can be produced, only those directed against proteins found in the virion envelope or infected cell membrane will be effective
 
**When targeted against free virus particles, antibodies are effective at preventing them binding and entering the cell and uncoating.
 
**When targeted against free virus particles, antibodies are effective at preventing them binding and entering the cell and uncoating.
**When targeting virus-infected cells, they aid antibody-dependent cell-mediated cytotoxicity by NK cells, macrophages and [[Neutrophils|neutrophils]]
+
**When targeting virus-infected cells, they aid antibody-dependent cell-mediated cytotoxicity by NK cells, [[Macrophages|macrophages]] and [[Neutrophils|neutrophils]]
    
*[[Complement]] - although not considered a major factor in defence against viruses, complement is able to damage the virion envelope (virolysis)
 
*[[Complement]] - although not considered a major factor in defence against viruses, complement is able to damage the virion envelope (virolysis)
495

edits